{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:01:50Z","timestamp":1785330110714,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,29]]},"DOI":"10.7759\/cureus.113586","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:13:51Z","timestamp":1785327231000},"source":"Crossref","is-referenced-by-count":0,"title":["Circadian Gene Networks and Transcriptome Oscillations in Prostate Cancer: Insights From RNA Sequencing and Implications for Chronotherapy"],"prefix":"10.7759","author":[{"given":"Ivan","family":"Bivolarski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hristo","family":"Dechev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70090","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung H","year":"2026","unstructured":"Sung H, Filho AM, Laversanne M, et al.. Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries. CA Cancer J Clin. 2026, 76:e70090. 10.3322\/caac.70090","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrg.2016.150","article-title":"Transcriptional architecture of the mammalian circadian clock","volume":"18","author":"Takahashi JS","year":"2017","unstructured":"Takahashi JS. Transcriptional architecture of the mammalian circadian clock. Nat Rev Genet. 2017, 18:164-79. 10.1038\/nrg.2016.150","journal-title":"Nat Rev Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30455-3","article-title":"Carcinogenicity of night shift work","volume":"20","author":"Ward EM","year":"2019","unstructured":"Ward EM, Germolec D. Carcinogenicity of night shift work. Lancet Oncol. 2019, 20:1058-9. 10.1016\/S1470-2045(19)30455-3","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-16-0366","article-title":"Women in cancer thematic review: circadian rhythmicity and the influence of 'clock' genes on prostate cancer","volume":"23","author":"Kiss Z","year":"2016","unstructured":"Kiss Z, Ghosh PM. Women in cancer thematic review: circadian rhythmicity and the influence of 'clock' genes on prostate cancer. Endocr Relat Cancer. 2016, 23:T123-34. 10.1530\/ERC-16-0366","journal-title":"Endocr Relat Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-025-10302-1","article-title":"The intricate interplay between circadian rhythm, androgen signaling, hormone therapy, and cellular senescence in prostate cancer","volume":"44","author":"Heidari Horestani M","year":"2025","unstructured":"Heidari Horestani M, Baniahmad A. The intricate interplay between circadian rhythm, androgen signaling, hormone therapy, and cellular senescence in prostate cancer. Cancer Metastasis Rev. 2025, 44:84. 10.1007\/s10555-025-10302-1","journal-title":"Cancer Metastasis Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0150-2","article-title":"RNA sequencing: the teenage years","volume":"20","author":"Stark R","year":"2019","unstructured":"Stark R, Grzelak M, Hadfield J. RNA sequencing: the teenage years. Nat Rev Genet. 2019, 20:631-56. 10.1038\/s41576-019-0150-2","journal-title":"Nat Rev Genet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1408886111","article-title":"A circadian gene expression atlas in mammals: implications for biology and medicine","volume":"111","author":"Zhang R","year":"2014","unstructured":"Zhang R, Lahens NF, Ballance HI, Hughes ME, Hogenesch JB. A circadian gene expression atlas in mammals: implications for biology and medicine. Proc Natl Acad Sci U S A. 2014, 111:16219-24. 10.1073\/pnas.1408886111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1619320114","article-title":"CYCLOPS reveals human transcriptional rhythms in health and disease","volume":"114","author":"Anafi RC","year":"2017","unstructured":"Anafi RC, Francey LJ, Hogenesch JB, Kim J. CYCLOPS reveals human transcriptional rhythms in health and disease. Proc Natl Acad Sci U S A. 2017, 114:5312-7. 10.1073\/pnas.1619320114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw405","article-title":"MetaCycle: an integrated R package to evaluate periodicity in large scale data","volume":"32","author":"Wu G","year":"2016","unstructured":"Wu G, Anafi RC, Hughes ME, Kornacker K, Hogenesch JB. MetaCycle: an integrated R package to evaluate periodicity in large scale data. Bioinformatics. 2016, 32:3351-3. 10.1093\/bioinformatics\/btw405","journal-title":"Bioinformatics"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/0748730410379711","article-title":"JTK_CYCLE: an efficient nonparametric algorithm for detecting rhythmic components in genome-scale data sets","volume":"25","author":"Hughes ME","year":"2010","unstructured":"Hughes ME, Hogenesch JB, Kornacker K. JTK_CYCLE: an efficient nonparametric algorithm for detecting rhythmic components in genome-scale data sets. J Biol Rhythms. 2010, 25:372-80. 10.1177\/0748730410379711","journal-title":"J Biol Rhythms"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2016.03.004","article-title":"Dosing-time makes the poison: circadian regulation and pharmacotherapy","volume":"22","author":"Dallmann R","year":"2016","unstructured":"Dallmann R, Okyar A, L\u00e9vi F. Dosing-time makes the poison: circadian regulation and pharmacotherapy. Trends Mol Med. 2016, 22:430-45. 10.1016\/j.molmed.2016.03.004","journal-title":"Trends Mol Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4199","article-title":"A role for the clock gene per1 in prostate cancer","volume":"69","author":"Cao Q","year":"2009","unstructured":"Cao Q, Gery S, Dashti A, Yin D, Zhou Y, Gu J, Koeffler HP. A role for the clock gene per1 in prostate cancer. Cancer Res. 2009, 69:7619-25. 10.1158\/0008-5472.CAN-08-4199","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2010.00767.x","article-title":"Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells","volume":"49","author":"Jung-Hynes B","year":"2010","unstructured":"Jung-Hynes B, Huang W, Reiter RJ, Ahmad N. Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells. J Pineal Res. 2010, 49:60-8. 10.1111\/j.1600-079X.2010.00767.x","journal-title":"J Pineal Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20513-5","article-title":"The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair","volume":"12","author":"Shafi AA","year":"2021","unstructured":"Shafi AA, McNair CM, McCann JJ, et al.. The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair. Nat Commun. 2021, 12:401. 10.1038\/s41467-020-20513-5","journal-title":"Nat Commun"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-0648","article-title":"Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study","volume":"69","author":"Zhu Y","year":"2009","unstructured":"Zhu Y, Stevens RG, Hoffman AE, et al.. Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Res. 2009, 69:9315-22. 10.1158\/0008-5472.CAN-09-0648","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-014-0478-z","article-title":"Circadian clock genes and risk of fatal prostate cancer","volume":"26","author":"Markt SC","year":"2015","unstructured":"Markt SC, Valdimarsdottir UA, Shui IM, et al.. Circadian clock genes and risk of fatal prostate cancer. Cancer Causes Control. 2015, 26:25-33. 10.1007\/s10552-014-0478-z","journal-title":"Cancer Causes Control"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1421204","article-title":"Exploring the interplay between circadian rhythms and prostate cancer: insights into androgen receptor signaling and therapeutic opportunities","volume":"12","author":"Xia H","year":"2024","unstructured":"Xia H, Zhan Y, Wang L, Wang X. Exploring the interplay between circadian rhythms and prostate cancer: insights into androgen receptor signaling and therapeutic opportunities. Front Cell Dev Biol. 2024, 12:1421204. 10.3389\/fcell.2024.1421204","journal-title":"Front Cell Dev Biol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2016.02.004","article-title":"Linking DNA damage and hormone signaling pathways in cancer","volume":"27","author":"Schiewer MJ","year":"2016","unstructured":"Schiewer MJ, Knudsen KE. Linking DNA damage and hormone signaling pathways in cancer. Trends Endocrinol Metab. 2016, 27:216-25. 10.1016\/j.tem.2016.02.004","journal-title":"Trends Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0271-8","article-title":"The emerging link between cancer, metabolism, and circadian rhythms","volume":"24","author":"Masri S","year":"2018","unstructured":"Masri S, Sassone-Corsi P. The emerging link between cancer, metabolism, and circadian rhythms. Nat Med. 2018, 24:1795-803. 10.1038\/s41591-018-0271-8","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao0318","article-title":"Diurnal transcriptome atlas of a primate across major neural and peripheral tissues","volume":"359","author":"Mure LS","year":"2018","unstructured":"Mure LS, Le HD, Benegiamo G, et al.. Diurnal transcriptome atlas of a primate across major neural and peripheral tissues. Science. 2018, 359:eaao0318. 10.1126\/science.aao0318","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-6-r54","article-title":"Regulation of alternative splicing by the circadian clock and food related cues","volume":"13","author":"McGlincy NJ","year":"2012","unstructured":"McGlincy NJ, Valomon A, Chesham JE, Maywood ES, Hastings MH, Ule J. Regulation of alternative splicing by the circadian clock and food related cues. Genome Biol. 2012, 13:R54. 10.1186\/gb-2012-13-6-r54","journal-title":"Genome Biol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2025.120062","article-title":"Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer","volume":"1873","author":"W\u00fcstmann N","year":"2026","unstructured":"W\u00fcstmann N, Reimann J, Vieler J, et al.. Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer. Biochim Biophys Acta Mol Cell Res. 2026, 1873:120062. 10.1016\/j.bbamcr.2025.120062","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2119","article-title":"Cotargeting androgen receptor splice variants and mTOR signaling pathway for the treatment of castration-resistant prostate cancer","volume":"22","author":"Kato M","year":"2016","unstructured":"Kato M, Banuelos CA, Imamura Y, et al.. Cotargeting androgen receptor splice variants and mTOR signaling pathway for the treatment of castration-resistant prostate cancer. Clin Cancer Res. 2016, 22:2744-54. 10.1158\/1078-0432.CCR-15-2119","journal-title":"Clin Cancer Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315815","article-title":"AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer","volume":"371","author":"Antonarakis ES","year":"2014","unstructured":"Antonarakis ES, Lu C, Wang H, et al.. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med. 2014, 371:1028-38. 10.1056\/NEJMoa1315815","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0406-4","article-title":"Machine learning identifies a compact gene set for monitoring the circadian clock in human blood","volume":"9","author":"Hughey JJ","year":"2017","unstructured":"Hughey JJ. Machine learning identifies a compact gene set for monitoring the circadian clock in human blood. Genome Med. 2017, 9:19. 10.1186\/s13073-017-0406-4","journal-title":"Genome Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.20214","article-title":"Blood transcriptome based biomarkers for human circadian phase","volume":"6","author":"Laing EE","year":"2017","unstructured":"Laing EE, M\u00f6ller-Levet CS, Poh N, Santhi N, Archer SN, Dijk DJ. Blood transcriptome based biomarkers for human circadian phase. Elife. 2017, 6:e20214. 10.7554\/eLife.20214","journal-title":"Elife"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1800314115","article-title":"Universal method for robust detection of circadian state from gene expression","volume":"115","author":"Braun R","year":"2018","unstructured":"Braun R, Kath WL, Iwanaszko M, et al.. Universal method for robust detection of circadian state from gene expression. Proc Natl Acad Sci U S A. 2018, 115:E9247-56. 10.1073\/pnas.1800314115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-25950-0_11","article-title":"Cancer chronotherapeutics: experimental, theoretical, and clinical aspects","volume":"217","author":"Ortiz-Tudela E","year":"2013","unstructured":"Ortiz-Tudela E, Mteyrek A, Ballesta A, Innominato PF, L\u00e9vi F. Cancer chronotherapeutics: experimental, theoretical, and clinical aspects. Handb Exp Pharmacol. 2013, 217:261-88. 10.1007\/978-3-642-25950-0_11","journal-title":"Handb Exp Pharmacol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1124\/pr.116.013441","article-title":"Systems chronotherapeutics","volume":"69","author":"Ballesta A","year":"2017","unstructured":"Ballesta A, Innominato PF, Dallmann R, Rand DA, L\u00e9vi FA. Systems chronotherapeutics. Pharmacol Rev. 2017, 69:161-99. 10.1124\/pr.116.013441","journal-title":"Pharmacol Rev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2019.07.002","article-title":"Interplay between circadian clock and cancer: new frontiers for cancer treatment","volume":"5","author":"Sulli G","year":"2019","unstructured":"Sulli G, Lam MT, Panda S. Interplay between circadian clock and cancer: new frontiers for cancer treatment. Trends Cancer. 2019, 5:475-94. 10.1016\/j.trecan.2019.07.002","journal-title":"Trends Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/510276-circadian-gene-networks-and-transcriptome-oscillations-in-prostate-cancer-insights-from-rna-sequencing-and-implications-for-chronotherapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:13:52Z","timestamp":1785327232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/510276-circadian-gene-networks-and-transcriptome-oscillations-in-prostate-cancer-insights-from-rna-sequencing-and-implications-for-chronotherapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.113586","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}